Methylene Blue Preserves Cytochrome Oxidase Activity and Prevents Neurodegeneration and Memory Impairment in Rats With Chronic Cerebral Hypoperfusion (2020)

Peer-Reviewed Study · Auchter AM, Barrett DW, Monfils MH, Gonzalez-Lima F · May 20, 2020

Auchter AM et al., 2020-05-20: Rat study showing that daily 4 mg/kg methylene blue preserved cytochrome oxidase activity in cortex, hippocampus and amygdala after permanent bilateral carotid occlusion and prevented associated neurodegeneration and learning impairment.

received daily 4 mg/kg methylene blue or saline injections, and learned a visual water task

abstract

Auchter AM et al., 2020-05-20: Rat study showing that daily 4 mg/kg methylene blue preserved cytochrome oxidase activity in cortex, hippocampus and amygdala after permanent bilateral carotid occlusion and prevented associated neurodegeneration and learning impairment. Study type: animal (rat) surgical model with quantitative cytochrome oxidase histochemistry and brain mapping. N not stated in abstract. Country: USA (University of Texas at Austin). Dose/route/schedule: 4 mg/kg daily injections for one month. Comparator: saline. Funder/conflicts: see article funding statement (Frontiers full text; declared in article). Note: quote taken from the PubMed abstract wording of the same article; the Frontiers full text was also opened. Study type: animal.